Literature DB >> 18583011

Low HDL cholesterol associates with major depression in a sample with a 7-year history of depressive symptoms.

Soili M Lehto1, Jukka Hintikka, Leo Niskanen, Tommi Tolmunen, Heli Koivumaa-Honkanen, Kirsi Honkalampi, Heimo Viinamäki.   

Abstract

Long-term depression may increase the risk for adverse coronary events. Low levels of high-density lipoprotein cholesterol (HDL-C) have in particular been suggested to underlie this connection. A total of 124 participants with a recorded seven-year history of depressive symptoms (depressed, n=63) or euthymic state (controls, n=61) underwent a Structured Clinical Interview for DSM-IV to confirm their psychiatric diagnosis. Total cholesterol (TC), HDL-C and low-density lipoprotein cholesterol (LDL-C) levels, triglycerides, non-HDL-C and atherogenic indices (LDL-C/HDL-C and TC/HDL-C) were assessed. The HDL-C levels were lower and atherogenic indices higher in the depressed group compared with the controls. Furthermore, those with HDL-C level below the gender-adjusted median (<1.54 mmol/l in women, <1.16 mmol/l in men) were 2.4-fold more likely to be depressed in a model adjusting for age and non-HDL-C (p=0.019). After further adjustment for educational level, marital status, alcohol use, daily smoking and overweight this association remained significant (p=0.049). These findings suggest that compared with the healthy controls, those with long-term depression may have lower HDL-C values and higher atherogenic indices.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583011     DOI: 10.1016/j.pnpbp.2008.05.021

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  22 in total

1.  Lipid trajectories as predictors of depressive symptoms: the Young Finns Study.

Authors:  Marko Elovainio; Laura Pulkki-Råback; Mika Kivimäki; Markus Jokela; Jorma Viikari; Olli T Raitakari; Risto Telama; Liisa Keltikangas-Järvinen
Journal:  Health Psychol       Date:  2010-05       Impact factor: 4.267

2.  Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men.

Authors:  Soili M Lehto; Anu Ruusunen; Leo Niskanen; Tommi Tolmunen; Sari Voutilainen; Heimo Viinamäki; George A Kaplan; Jussi Kauhanen
Journal:  Eur J Epidemiol       Date:  2010-04-23       Impact factor: 8.082

3.  Metabolic Effects of Antidepressant Treatment.

Authors:  Özlem Olguner Eker; Saliha Özsoy; Baki Eker; Hatice Doğan
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

Review 4.  Depression and serum low-density lipoprotein: A systematic review and meta-analysis.

Authors:  Jane E Persons; Jess G Fiedorowicz
Journal:  J Affect Disord       Date:  2016-07-19       Impact factor: 4.839

5.  Relations of depressive symptoms and antidepressant use to body mass index and selected biomarkers for diabetes and cardiovascular disease.

Authors:  Yunsheng Ma; Raji Balasubramanian; Sherry L Pagoto; Kristin L Schneider; James R Hébert; Lawrence S Phillips; Joseph S Goveas; Annie L Culver; Barbara C Olendzki; James Beck; Jordan W Smoller; Deidre M Sepavich; Judith K Ockene; Lisa Uebelacker; Martha Zorn; Simin Liu
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

6.  Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans.

Authors:  Rene L Olvera; Douglas E Williamson; Susan P Fisher-Hoch; Kristina P Vatcheva; Joseph B McCormick
Journal:  J Clin Psychiatry       Date:  2015-10       Impact factor: 4.384

7.  Association between lipid profile and depressive symptoms among Chinese older people: mediation by cardiovascular diseases?

Authors:  Yajun Liang; Zhongrui Yan; Chuanzhu Cai; Hui Jiang; Aiqin Song; Chengxuan Qiu
Journal:  Int J Behav Med       Date:  2014-08

8.  Association of depressive disorder with biochemical and anthropometric indices in adult men and women.

Authors:  Bum Ju Lee
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

9.  Increased Levels of Acetylcholinesterase, Paraoxonase 1, and Copper in Patients with Moderate Depression- a Preliminary Study.

Authors:  Shobha Ullas Kamath; Abhishek Chaturvedi; Devesh Bhaskar Yerrapragada; Nagendra Kundapura; Navaneeth Amin; Virupaksha Devaramane
Journal:  Rep Biochem Mol Biol       Date:  2019-01

10.  Nutritional status and eating habits of people who use drugs and/or are undergoing treatment for recovery: a narrative review.

Authors:  Nadine Mahboub; Rana Rizk; Mirey Karavetian; Nanne de Vries
Journal:  Nutr Rev       Date:  2021-05-12       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.